Integration of a physiologically-based pharmacokinetic model with a whole-body, organ-resolved genome-scale model for characterization of ethanol and acetaldehyde metabolism.
Ethanol is one of the most widely used recreational substances in the world and due to its ubiquitous use, ethanol abuse has been the cause of over 3.3 million deaths each year. In addition to its effects, ethanol's primary metabolite, acetaldehyde, is a carcinogen that can cause symptoms of fa...
Guardado en:
Autores principales: | Leo Zhu, William Pei, Ines Thiele, Radhakrishnan Mahadevan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/750b9ac7fd004fc2a30558506bfe19d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ethanol Dehydrogenation to Acetaldehyde over Co@N-Doped Carbon
por: Aleksey N. Chernov, et al.
Publicado: (2021) -
Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model.
por: Elhaseen Elamin, et al.
Publicado: (2012) -
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
por: Muhammad F. Rasool, et al.
Publicado: (2021) -
The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development
por: Cvijić Sandra, et al.
Publicado: (2021) -
Prospects and limitations of physiologically-based pharmacokinetic modelling for cross-species extrapolation
por: Lars Kuepfer
Publicado: (2019)